arrow
Back
A

Ali Seddighzadeh

Biogen

14H-index
41Paper Count
1.1KCitation Count
Published Papers 6
Publication Date
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children
err2022-03-01
err44
errOAAI
errSas, David J.; Magen, Daniella; Hayes, Wesley; Shasha-Lavsky, Hadas; Michael, Mini; Schulte, Indra; Sellier-Leclerc, Anne-Laure; Lu, Jiandong; Seddighzadeh, Ali; Habtemariam, Bahru; McGregor, Tracy L.; Fujita, Kenji P.; Frishberg, Yaacov
errShare
errSave
Deep vein thrombosis in patients with chronic kidney disease
err2017-11-27
err32
PREAI
errDaneschvar, H. Leon; Seddighzadeh, Ali; Piazza, Gregory; Goldhaber, Samuel Z.
errShare
errSave
COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects
err2016-05-29
err23
errOAAI
errHu, Xiao; Shang, Shulian; Nestorov, Ivan; Hasan, Jawad; Seddighzadeh, Ali; Dawson, Katherine; Sperling, Bjorn; Werneburg, Brian
errShare
errSave
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
err2014-11-28
err82
errOAAI
errKieseier, Bernd C.; Arnold, Douglas L.; Balcer, Laura J.; Boyko, Alexey A.; Pelletier, Jean; Liu, Shifang; Zhu, Ying; Seddighzadeh, Ali; Hung, Serena; Deykin, Aaron; Sheikh, Sarah I.; Calabresi, Peter A.
errShare
errSave
errShare
errSave